十一月 2025
- Home
- Dexcom
十一月 2025的Dexcom市场份额分析
DexCom, Inc. is a company that develops, manufactures, produces, and distributes continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has manufacturing facilities in Mesa, Arizona and Batu Kawan, Malaysia.
显示 Dexcom 主网站(包括公司地区网站)的流量和参与度信息
查看更多网站流量和参与度信息- dexcom.com
- amsldiabetes.com.au
- nzmsdiabetes.co.nz
Dexcom收入截至 十一月 2025为 > 1B
Dexcom主要域名产生的收入
3 年中Dexcom主要域名的收入
Dexcom主要域名的收入
十一月 2025的Dexcom股票价格
Dexcom的股票交易代码为 DXCM。您可以在下面查看过去 12 个月的Dexcom股票表现(最多 十一月 2025)
Dexcom热门域名的总访问量
了解Dexcom市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Dexcom热门域名的平均访问时长
分析Dexcom参与度指标。
过去 3 个月的平均访问时长
子公司明细
Dexcom热门域名的平均页面浏览量
了解Dexcom如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Dexcom 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Dexcom, Inc. has issues with recall and several lawsuits.* DexCom was hit with a recall and several lawsuits after some customers complained about its devices.
十一月 11, 2025阅读更多
新闻Dexcom, Inc. is developing feature for people with Type 2 diabetes based on G7 platform.Dexcom is working on a new feature for people with Type 2 diabetes based on its G7 platform.
十月 31, 2025阅读更多
新闻Dexcom, Inc. launched Stelo on Mar 1st '24.Dexcom introduced Stelo, the first over-the-counter (OTC) continuous glucose monitor cleared by the FDA in March 2024 for non-insulin using adults - both those with type 2 diabetes and people without diabetes.
十月 15, 2025阅读更多
查看 Dexcom 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。